Company intelligence / Profile preview
Arnav Biotech
Atlanta, Georgia, USAarnavbiotech.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Arnav Biotech has secured an exclusive license for a novel anti-RSV inhibitor from Alabama State University and is progressing this candidate through preclinical/IND-enabling studies. The company’s pipeline includes broad-spectrum antiviral mRNAs and vaccines targeting high-burden infectious diseases. They have established collaborations to develop robust manufacturing/purification processes supporting their clinical advancement.
- Therapeutic areas
- Rare DiseasesInfectious Diseases
- Modalities
- mRNA-based therapeuticsmRNA vaccinesCRISPR-based genetic and epigenetic modulatorslipid nanoparticles
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Sartorius BIA Separations (for purification/analytics platform)Emory UniversityGeorgia TechCincinnati Children's Hospital Medical Center (CCHMC)ClearB Therapeutics
Beyond the preview
Go deeper on Arnav Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arnav Biotech.